Sign in

    Shawn O’Connor

    Chief Executive Officer at Simulations Plus Inc
    Since June 1, 2018
    Age
    65 years
    Education
    Earned a Bachelor of Science in Business Administration from the University of California at Berkeley and completed an Executive Education Program at Stanford University Graduate School of Business.
    Tenure
    Has served as Chief Executive Officer at Simulations Plus since June 2018, joining the company to drive its strategic growth and market expansion.

    Also at Simulations Plus Inc

    DS
    Daniel Szot
    Chief Revenue Officer (CRO)
    JR
    Jenna Rouse
    President of the Adaptive Learning & Insights business unit
    JF
    Jill Fiedler-Kelly
    President, Clinical Pharmacology & Pharmacometric Services

    About

    Shawn O’Connor is a seasoned executive with over 31 years of experience in high-technology management, particularly in software and services for the pharmaceutical and biotechnology industries.

    His career includes significant leadership roles, having served as CEO, President, and CFO at organizations such as Entelos Holding Corp., Pharsight Corporation, QRS Corporation, and Diasonics, Inc..

    Since joining Simulations Plus in June 2018 as Chief Executive Officer, he has led strategic initiatives that have broadened the company's offerings and market presence, including key acquisitions and restructuring efforts.

    $SLP Performance Under Shawn O’Connor

    Past Roles

    Organization Role Date Range Details
    Entelos Holding Corp.Chief Executive Officer, President, and Director2011 to 2018Provided quantitative systems pharmacology software and services to the pharmaceutical drug development market
    Pharsight CorporationChief Executive Officer, President, and Chairman2002 to 2009Developed and marketed software products and services to aid pharmaceutical and biotechnology companies in decision-making
    QRS CorporationChief Financial Officer, President, and Chief Operating Officer1995 to 2000Specific business focus during his tenure is not detailed in the documents
    Diasonics, Inc.Various positions, including Chief Financial Officer1988 to 1994Specific business focus during his tenure is not detailed in the documents

    Fixed Compensation

    Data from  FY 2024
    Component NameAmountPayment ScheduleAdditional Details
    Base Salary$511,608 AnnuallyFixed base salary for fiscal year 2024.
    All Other Compensation$3,812 AnnuallyIncludes 401(k) matching, vacation payout, life insurance premiums, and health savings matching contributions.

    Performance Compensation

    Data from  FY 2024

    Cash Bonus

    MetricWeightTarget AmountThresholds & Conditions
    Company Performance Metrics80% $308,880 Must achieve between 80% and 120% of budgeted revenue and net income; linear interpolation applied; acquisitions excluded.
    Individual Performance Metrics20% $77,220 Based on four objectives: acquisition target identification, succession plan development, ESG progress, and leadership assessment.

    Stock Option Awards

    DetailInformation
    Grant DateOctober 19, 2023
    Number of Options50,000
    Exercise Price$39.98
    Grant Date Fair Value$990,000
    Vesting Schedule40% vesting on the 1st anniversary, 30% on the 2nd, 30% on the 3rd
    Performance MetricsNo specific performance thresholds provided for option awards.